pharma · Type 1 Diabetes Mellitus · Prophylaxis of Renal Allograft Rejection · ELDN
Eledon Pharmaceuticals
Eledon Pharmaceuticals trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Irvine, USA HQ
2020 Founded
42 Employees
Public company Type
ELDN · NYSE Ticker
Company details
- Status
- Public
- HQ
- Irvine, USA
- Founded
- 2020
- Employees
- 42
- Programs
- 9
- Drugs
- 11
- Patents
- 0
Eledon Pharmaceuticals clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to Eledon Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
Eledon Pharmaceuticals trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Eledon Pharmaceuticals.
-
AT-1501-K209 — Phase 2
Clinical update -
2025P000818 — Phase 1
Clinical update -
Islet transplantation with Tegoprubart (AT-1501) immunosupression-based therapy — Phase 2
Clinical update -
AT-1501 IV Infusion — Phase 2
Clinical update -
AT-1501 — Phase 2
Clinical update -
AT-1501 — Phase 2
Clinical update -
AT-1501 — Phase 2
Clinical update -
AT-1501 — Phase 2
Clinical update